Retirement Systems of Alabama Has $23.37 Million Stock Position in Encompass Health Corporation (NYSE:EHC)

Retirement Systems of Alabama cut its stake in shares of Encompass Health Corporation (NYSE:EHC - Free Report) by 16.3% during the first quarter, according to its most recent disclosure with the SEC. The institutional investor owned 230,738 shares of the company's stock after selling 45,066 shares during the period. Retirement Systems of Alabama owned about 0.23% of Encompass Health worth $23,369,000 at the end of the most recent reporting period.

Other hedge funds and other institutional investors also recently added to or reduced their stakes in the company. Vanguard Group Inc. raised its holdings in shares of Encompass Health by 1.3% during the fourth quarter. Vanguard Group Inc. now owns 10,404,081 shares of the company's stock worth $960,817,000 after acquiring an additional 138,196 shares in the last quarter. Invesco Ltd. raised its stake in shares of Encompass Health by 3.3% during the 4th quarter. Invesco Ltd. now owns 5,536,251 shares of the company's stock worth $511,273,000 after purchasing an additional 176,135 shares in the last quarter. Alliancebernstein L.P. grew its stake in shares of Encompass Health by 6.0% in the 4th quarter. Alliancebernstein L.P. now owns 2,076,869 shares of the company's stock valued at $191,799,000 after buying an additional 117,617 shares in the last quarter. FMR LLC increased its holdings in Encompass Health by 0.8% in the fourth quarter. FMR LLC now owns 1,973,846 shares of the company's stock worth $182,285,000 after buying an additional 15,831 shares during the last quarter. Finally, Geode Capital Management LLC raised its position in Encompass Health by 0.4% during the fourth quarter. Geode Capital Management LLC now owns 1,679,774 shares of the company's stock valued at $155,176,000 after acquiring an additional 6,164 shares in the last quarter. Hedge funds and other institutional investors own 97.25% of the company's stock.

Encompass Health Trading Up 0.7%

Shares of Encompass Health stock traded up $0.79 on Tuesday, hitting $121.01. 575,010 shares of the company's stock traded hands, compared to its average volume of 702,130. The firm's 50-day moving average price is $116.14 and its two-hundred day moving average price is $104.12. The company has a debt-to-equity ratio of 0.81, a current ratio of 1.06 and a quick ratio of 1.06. The stock has a market capitalization of $12.20 billion, a PE ratio of 25.00, a price-to-earnings-growth ratio of 2.42 and a beta of 0.89. Encompass Health Corporation has a one year low of $82.74 and a one year high of $123.13.

Encompass Health (NYSE:EHC - Get Free Report) last issued its earnings results on Thursday, April 24th. The company reported $1.37 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $1.19 by $0.18. The firm had revenue of $1.46 billion for the quarter, compared to analysts' expectations of $1.43 billion. Encompass Health had a return on equity of 17.63% and a net margin of 8.97%. The company's revenue was up 10.6% compared to the same quarter last year. During the same quarter last year, the business earned $1.12 earnings per share. On average, research analysts expect that Encompass Health Corporation will post 4.8 EPS for the current fiscal year.

Encompass Health Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Tuesday, July 15th. Shareholders of record on Tuesday, July 1st will be paid a $0.17 dividend. The ex-dividend date is Tuesday, July 1st. This represents a $0.68 dividend on an annualized basis and a yield of 0.56%. Encompass Health's payout ratio is 14.05%.

Insider Transactions at Encompass Health

In other news, CEO Mark J. Tarr sold 118,384 shares of the company's stock in a transaction dated Tuesday, May 20th. The stock was sold at an average price of $121.53, for a total transaction of $14,387,207.52. Following the completion of the transaction, the chief executive officer now directly owns 527,070 shares of the company's stock, valued at $64,054,817.10. This represents a 18.34% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, insider Elissa Joy Charbonneau sold 4,279 shares of Encompass Health stock in a transaction that occurred on Tuesday, May 6th. The shares were sold at an average price of $116.61, for a total value of $498,974.19. Following the completion of the sale, the insider now directly owns 11,958 shares in the company, valued at approximately $1,394,422.38. This represents a 26.35% decrease in their position. The disclosure for this sale can be found here. Insiders have sold a total of 132,663 shares of company stock valued at $16,034,082 over the last 90 days. 2.00% of the stock is owned by company insiders.

Analysts Set New Price Targets

Several research analysts have recently commented on the stock. Truist Financial restated a "buy" rating and set a $135.00 price target (up previously from $116.00) on shares of Encompass Health in a research note on Monday, April 28th. Barclays upped their target price on shares of Encompass Health from $118.00 to $129.00 and gave the company an "overweight" rating in a research note on Friday, April 25th. KeyCorp boosted their price objective on shares of Encompass Health from $122.00 to $135.00 and gave the stock an "overweight" rating in a report on Tuesday, May 27th. UBS Group increased their target price on shares of Encompass Health from $117.00 to $130.00 and gave the company a "buy" rating in a research note on Monday, April 28th. Finally, Stephens raised Encompass Health from an "overweight" rating to a "strong-buy" rating and set a $135.00 price target for the company in a report on Thursday, June 5th. Eight analysts have rated the stock with a buy rating and two have given a strong buy rating to the stock. According to MarketBeat, the company currently has a consensus rating of "Buy" and an average price target of $127.00.

About Encompass Health

Encompass Health Corporation provides post-acute healthcare services in the United States and Puerto Rico. It owns and operates inpatient rehabilitation hospitals that provide medical, nursing, therapy, and ancillary services. The company provides specialized rehabilitative treatment on an inpatient basis to patients who have experienced physical or cognitive disabilities or injuries due to medical conditions, such as strokes, hip fractures, and various debilitating neurological conditions.